Top Regulation/Legislation Stories
46 states accuse drugmakers of price collusion in latest lawsuit
By David McLaughlin and Riley GriffinThe case is the third major complaint in a six-year investigation that focuses on pharmaceutical companies.
News and information for insurance company (carrier) executives on compliance issues, including court rulings, new statutes & laws and other factors that influence how organizations remain compliant with authorities at both the state and federal level.
The case is the third major complaint in a six-year investigation that focuses on pharmaceutical companies.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely property casualty news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.